Soo-Chin Lee Selected Research

17-dihydroexemestane

1/2015

Validation of a rapid and sensitive LC-MS/MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: application to human pharmacokinetics study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Soo-Chin Lee Research Topics

Disease

43	Neoplasms (Cancer) 01/2023 - 04/2006
32	Breast Neoplasms (Breast Cancer) 05/2024 - 12/2007
6	Neutropenia 11/2023 - 12/2010
4	Lung Neoplasms (Lung Cancer) 01/2023 - 07/2008
4	Peripheral Nervous System Diseases (PNS Diseases) 08/2020 - 01/2016
4	Hepatocellular Carcinoma (Hepatoma) 01/2013 - 08/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 07/2008
3	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2016
3	Hypothermia 08/2020 - 01/2016
3	Triple Negative Breast Neoplasms 01/2020 - 08/2014
2	Carcinogenesis 01/2023 - 01/2020
2	Diarrhea 12/2016 - 06/2016
2	Liver Neoplasms (Liver Cancer) 01/2013 - 09/2010
2	Thrombocytopenia (Thrombopenia) 09/2011 - 12/2010
2	Nasopharyngeal Carcinoma 02/2009 - 01/2006
1	Overweight 11/2023
1	Familial Breast Cancer 01/2023
1	Carcinoma (Carcinomatosis) 10/2019
1	Retinoblastoma (Glioblastoma, Retinal) 11/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018
1	Leukopenia 12/2016
1	Turcot syndrome 08/2016
1	Circulating Neoplastic Cells 08/2016
1	Liver Diseases (Liver Disease) 02/2016
1	Adenocarcinoma 02/2015
1	Colorectal Neoplasms (Colorectal Cancer) 02/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2013
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2013
1	Lymphatic Metastasis 01/2012
1	Oncogene Addiction 01/2012

Drug/Important Bio-Agent (IBA)

9	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 07/2008
8	Biomarkers (Surrogate Marker)IBA 05/2024 - 10/2009
8	Docetaxel (Taxotere)FDA Link 11/2020 - 12/2007
5	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 08/2008
5	Hormones (Hormone)IBA 11/2023 - 01/2012
5	Paclitaxel (Taxol)FDA LinkGeneric 08/2020 - 01/2016
4	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2012
4	Phosphotransferases (Kinase)IBA 01/2020 - 04/2012
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 01/2006
4	Gemcitabine FDA Link 09/2011 - 07/2008
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2012
3	Estrogen ReceptorsIBA 10/2019 - 04/2012
3	Lapatinib (GW572016)FDA Link 12/2016 - 08/2008
3	Carboplatin (JM8)FDA LinkGeneric 09/2011 - 07/2008
2	Sunitinib (Sutent)FDA Link 11/2020 - 09/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020 - 09/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2018 - 02/2009
2	Tyrosine Kinase InhibitorsIBA 12/2016 - 01/2006
2	AnthracyclinesIBA 09/2016 - 12/2010
2	Cell-Free Nucleic AcidsIBA 08/2016 - 02/2015
2	GlucuronidesIBA 01/2016 - 01/2013
2	exemestane (Aromasin)FDA Link 01/2015 - 11/2011
2	Histone Deacetylase InhibitorsIBA 01/2013 - 11/2011
2	belinostatIBA 01/2013 - 09/2010
2	gemcitabine triphosphateIBA 12/2008 - 07/2008
2	Ketoconazole (Nizoral)FDA LinkGeneric 07/2008 - 04/2006
1	palbociclibIBA 11/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Adenosine Monophosphate (AMP)IBA 01/2023
1	InterleukinsIBA 01/2023
1	CytokinesIBA 01/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	lenvatinibIBA 01/2022
1	ribociclibIBA 01/2021
1	taxaneIBA 08/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 07/2018
1	imidazoleacetic acid (IMAC)IBA 01/2018
1	neratinibIBA 12/2016
1	Immune Checkpoint InhibitorsIBA 08/2016
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 06/2016
1	CaspasesIBA 01/2016
1	Mevalonic Acid (Mevalonate)IBA 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Simvastatin (Zocor)FDA LinkGeneric 01/2016
1	Cell Cycle ProteinsIBA 01/2016
1	Neuroprotective AgentsIBA 01/2016
1	Raltegravir Potassium FDA Link 01/2016
1	Capecitabine (Xeloda)FDA Link 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	regorafenibIBA 02/2015
1	17-dihydroexemestaneIBA 01/2015
1	EnzymesIBA 01/2015
1	sphingosine kinaseIBA 08/2014
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 02/2013
1	Vorinostat FDA Link 11/2011
1	Uridine Diphosphate (UDP)IBA 11/2011
1	Ibuprofen (Motrin)FDA LinkGeneric 11/2011

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 11/2023 - 03/2009
16	Therapeutics 11/2023 - 08/2008
2	Precision Medicine 10/2020 - 11/2016
2	Radiotherapy 11/2016 - 11/2015
1	Complementary Therapies (Alternative Medicine) 07/2021
1	Neoadjuvant Therapy 08/2016
1	Mastectomy (Mammectomy) 11/2015
1	Segmental Mastectomy (Lumpectomy) 11/2015
1	Adjuvant Radiotherapy 11/2015
1	Molecular Targeted Therapy 01/2012